Trial intelligence / Profile preview

HPV Vaccination in Adolescent and Young Female Tumor Survivors

ChiCTR2300077687Phase 2Not yet recruiting

Sponsor
Shanghai Children's Medical Center
Start
Dec 2023
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of human papillomavirus vaccine in human papillomavirus infection, Cervical Cancer (CC), anogenital warts and 1 more, sponsored by Shanghai Children's Medical Center. Planned start Dec 2023; status: not yet recruiting.

02

Drugs

human papillomavirus vaccine
03

Conditions

human papillomavirus infectionCervical Cancer (CC)anogenital wartshuman papillomavirus-associated cancer

Beyond the preview

Go deeper on ChiCTR2300077687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300077687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call